A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma

Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease that requires precise diagnosis for effective treatment. However, the diagnostic value of carbohydrate antigen 19 − 9 (CA19-9) is limited. Therefore, this study aims to identify novel tumor-associated autoantibodies...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tiandong Li, Junfen Xia, Huan Yun, Guiying Sun, Yajing Shen, Peng Wang, Jianxiang Shi, Keyan Wang, Hongwei Yang, Hua Ye
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-11-01
coleção:	Cancer Cell International
Assuntos:	Pancreatic ductal adenocarcinoma Autoantibody Diagnosis Immunodiagnostic Model
Acesso em linha:	https://doi.org/10.1186/s12935-023-03107-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!